World, meet iQ. iQ, meet world.

This week in Chicago we formally introduced the world to the iQ - a truly disruptive technology that will revolutionize the way drugs are developed and tested for cardiac safety.

I've talked about this project in the past from a technical perspective, but for non-geeks: at a high level this thing makes it dead simple for pharmaceutical companies to ensure that ALL of their later-phase drug trials have board certified cardiologists looking things over.

Here's a picture from the DIA trade show. Over three days, we demonstrated nearly 60 ECG acquisitions. In each case we were able to correctly identify Andrew (the poor guy with no shirt) from our subject database using voice biometrics 100% of the time.